Source link : https://newshealth.biz/health-news/pembrolizumab-crt-the-new-standard-of-care-in-locally-advanced-cervical-cancer/
(MedPage Today) — A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer, according to results from the KEYNOTE-A18 trial… Source link : https://www.medpagetoday.com/meetingcoverage/sgo/114673 Author : Publish date : 2025-03-15 17:43:00 Copyright for syndicated content belongs to the linked Source.
The post Pembrolizumab-CRT: The New Standard of Care in Locally Advanced Cervical Cancer? first appeared on News Health.
Author : News Health
Publish date : 2025-03-15 17:43:00
Copyright for syndicated content belongs to the linked Source.
in Health